Valeant Ends Fight With Par Over Generic Antidepressant
A unit of Valeant Pharmaceuticals International Inc. on Thursday resolved its suit in New York federal court accusing Par Pharmaceutical Cos. Inc. of infringing its patents by seeking to launch a...To view the full article, register now.
Already a subscriber? Click here to view full article